Literature DB >> 30172430

Early Antibiotic Exposure and Adverse Outcomes in Preterm, Very Low Birth Weight Infants.

Joseph B Cantey1, Alaina K Pyle2, Phillip S Wozniak3, Linda S Hynan4, Pablo J Sánchez5.   

Abstract

OBJECTIVES: To determine whether antibiotic use in the first 14 postnatal days in preterm, very low birth weight (birth weight of ≤1500 g) infants is associated with risk after 14 days of age for late-onset sepsis, necrotizing enterocolitis (NEC), or death after controlling for severity of illness using the Clinical Risk Index in Babies II score, and determine whether duration of antibiotic exposure was associated with risk of adverse outcomes. STUDY
DESIGN: This retrospective cohort study included very low birth weight infants born at ≤326/7 weeks of gestation admitted to the neonatal intensive care unit from September 2010 to June 2014. Infants were excluded if they had major congenital anomalies or culture-proven sepsis, NEC, or death during the first 14 days of life. Antibiotic exposure was recorded as days of therapy and length of therapy in days.
RESULTS: Of 374 infants, 70 (19%) had late-onset sepsis, NEC, or death after 14 days of age. The median number of antibiotic days of therapy and length of therapy were 5.5 and 3.0, respectively. In multivariate analysis after controlling for severity of illness, each antibiotic day of therapy was associated with a 1.24 times increased risk of sepsis, NEC, or death (OR, 1.24; 95% CI, 1.17-1.31). Risk was similar when length of therapy was used (OR, 1.47; 95% CI, 1.32-1.64).
CONCLUSIONS: After controlling for severity of illness, each day of antibiotic therapy provided to preterm, very low birth weight infants in the first 2 weeks of age is associated with an increased risk of late-onset sepsis, NEC, or death.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  neonatal intensive care unit; neonate; sepsis; stewardship

Mesh:

Substances:

Year:  2018        PMID: 30172430     DOI: 10.1016/j.jpeds.2018.07.036

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Impact of Early-Onset Sepsis and Antibiotic Use on Death or Survival with Neurodevelopmental Impairment at 2 Years of Age among Extremely Preterm Infants.

Authors:  Sagori Mukhopadhyay; Karen M Puopolo; Nellie I Hansen; Scott A Lorch; Sara B DeMauro; Rachel G Greenberg; C Michael Cotten; Pablo J Sánchez; Edward F Bell; Eric C Eichenwald; Barbara J Stoll
Journal:  J Pediatr       Date:  2020-06       Impact factor: 4.406

Review 2.  Spontaneous intestinal perforation (SIP) will soon become the most common form of surgical bowel disease in the extremely low birth weight (ELBW) infant.

Authors:  Jonathan R Swanson; Amy Hair; Reese H Clark; Phillip V Gordon
Journal:  J Perinatol       Date:  2022-02-17       Impact factor: 2.521

Review 3.  Artificial and human intelligence for early identification of neonatal sepsis.

Authors:  Brynne A Sullivan; Sherry L Kausch; Karen D Fairchild
Journal:  Pediatr Res       Date:  2022-09-20       Impact factor: 3.953

4.  [Effect of improvement in antibiotic use strategy on the short-term clinical outcome of preterm infants with a gestational age of <35 weeks].

Authors:  Mei-Yan Chu; Ming-Jie Wang; Jin Lin; Ge Yang; Ying Ding; Zheng-Chang Liao; Chuan-Ding Cao; Shao-Jie Yue
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

Review 5.  Congenital Infection Influence on Early Brain Development Through the Gut-Brain Axis.

Authors:  Gregory W Kirschen; Snigdha Panda; Irina Burd
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

6.  Vagal Tone and Proinflammatory Cytokines Predict Feeding Intolerance and Necrotizing Enterocolitis Risk.

Authors:  Alissa L Meister; Fumiyuki C Gardner; Kirsteen N Browning; R Alberto Travagli; Charles Palmer; Kim Kopenhaver Doheny
Journal:  Adv Neonatal Care       Date:  2021-12-01       Impact factor: 1.874

7.  Umbilical cord blood culture in neonatal early-onset sepsis: a systematic review and meta-analysis.

Authors:  Thomas H Dierikx; Anton H L C van Kaam; Tim G J de Meij; Ralph de Vries; Wes Onland; Douwe H Visser
Journal:  Pediatr Res       Date:  2021-10-28       Impact factor: 3.953

8.  Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Authors:  Mark A Underwood; Erin Umberger; Ravi M Patel
Journal:  Pediatr Res       Date:  2020-08       Impact factor: 3.756

9.  Influence of Patient Characteristics on Antibiotic Use Rates Among Preterm Infants.

Authors:  Dustin D Flannery; Sagori Mukhopadhyay; Erik A Jensen; Jeffrey S Gerber; Molly R Passarella; Kevin Dysart; Zubair H Aghai; Jay Greenspan; Karen M Puopolo
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

10.  Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research.

Authors:  Béatrice Gouyon; Séverine Martin-Mons; Silvia Iacobelli; Hasinirina Razafimahefa; Elsa Kermorvant-Duchemin; Roselyne Brat; Laurence Caeymaex; Yvan Couringa; Ceneric Alexandre; Catherine Lafon; Duksha Ramful; Francesco Bonsante; Guillaume Binson; Florence Flamein; Amélie Moussy-Durandy; Massimo Di Maio; Gaël Mazeiras; Olivier Girard; Cécile Desbruyeres; Julien Mourdie; Guillaume Escourrou; Olivier Flechelles; Soumeth Abasse; Jean-Marc Rosenthal; Anne-Sophie Pages; Marine Dorsi; Léila Karaoui; Abdellah ElGellab; Florence Le Bail Dantec; Mohamed-Amine Yangui; Karine Norbert; Yaovi Kugbe; Simon Lorrain; Anaelle Pignolet; Elodie Marie Garnier; Alexandre Lapillonne; Delphine Mitanchez; Evelyne Jacqz-Aigrain; Jean-Bernard Gouyon
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.